Prediction of survival and therapy outcome with 11C-tyrosine PET in patients with laryngeal carcinoma

Journal of Nuclear Medicine

Volumn 45, Issue 12, 2004, Pages 2052-2057

  De Boer, Jurjan R ^a   Pruim, Jan ^a   Albers, Frans W J ^a   Burlage, Fred ^a   Vaalburg, Willem ^a   Van Der Laan, Bernard F A M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Head and neck tumors; L 1 11C tyrosine; PET; Prediction; Survival; Therapy outcome

Indexed keywords

RADIOPHARMACEUTICAL AGENT; TYROSINE C 11; UNCLASSIFIED DRUG; CARBON; DIAGNOSTIC AGENT; TYROSINE;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LARYNX CARCINOMA; MALE; NECK DISSECTION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TREATMENT OUTCOME; LARYNX TUMOR; METABOLISM; METHODOLOGY; MIDDLE AGED; MORTALITY; SCINTISCANNING; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE;

ADULT; AGED; CARBON RADIOISOTOPES; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; SURVIVAL RATE; TYROSINE;

EID: 16644368085     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Adams GL. Treatment of head and neck cancer with combined modalities. Invest Radiol. 1989;24:562-567.
2. Wang CC. Radiation Therapy for Head and Neck Neoplasms: Indications, Techniques, and Results. New York, NY: Wiley-Liss; 1997:63-78.
3. 18F-FDG and PET in head and neck cancer. J Nucl Med. 1997;38:1907-1911.
4. Strauss LG. Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients. Eur J Nucl Med. 1996;23:1409-1415.
5. de Boer JR, van der Laan BFAM, Pruim J, et al. C-11-Tyrosine PET for visualization and protein synthesis rate assessment of laryngeal and hypopharyngeal carcinomas. Eur J Nucl Med. 2002;29:1182-1187.
6. 11C]-tyrosine and PET. J Nucl Med. 1995;36:411-419.
7. Kole AC, Pruim J, Nieweg OE, et al. PET with L-[1-carbon-11]- tyrosine to visualize tumors and measure protein synthesis rates. J Nucl Med. 1997;38:191-195.
8. 11C]-tyrosine PET to evaluate response to hyperthermic isolated limb perfusion for locally advanced soft-tissue sarcoma and skin cancer. J Nucl Med. 1999;40:262-267.
9. Pruim J, Willemsen AT, Molenaar WM, et al. Brain tumors: L-[1-C-11]-tyrosine PET for visualization and quantification of protein synthesis rate. Radiology. 1995;197:221-226.
10. International Union Against Cancer. Primary Tumor, Regional Nodes and Metastasis (TNM) Atlas Classification of Malignant Tumors. Berlin, Germany: Springer-Verlag; 1997.
11. Thorell JO, Stone-Elander S, Elander N. Use of a microwave cavity to reduce reaction times in radiolabelling with [11-C]cyanide. J Labelled Compds Radiopharm. 1992;31:207-217.
12. Bailey BJ. Beyond the "new" TNM classification [editorial]. Arch Otolaryngol Head Neck Surg. 1991;117:369-370.
13. Alavi JB, Alavi A, Chawluk J, et al. Positron emission tomography in patients with glioma: a predictor of prognosis. Cancer. 1988;62:1074-1078.
14. Van Ginkel RJ, Hoekstra HJ, Pruim J, et al. FDG PET to evaluate response to hyperthermic isolated limb perfusion for locally advanced soft-tissue sarcoma. J Nucl Med. 1996;37:984-990.
15. 11C-methionine. Int J Rad Oncol Biol Phys. 1995;32:787-794.
16. 11C]methionine-positron emission tomography. Radiother Oncol. 1999;52:225-232.
17. Lindholm P, Leskinen S, Lapela M. Carbon-11-methionine uptake in squamous cell head and neck cancer. J Nucl Med. 1998;39:1393-1397.
18. Jager PL, Vaalburg W, Pruim J, de Vries EG, Langen KJ, Piers DA. Radiolabeled amino acids: basic aspects and clinical applications in oncology. J Nucl Med. 2001;42:432-445.
19. 11C]methionine uptake in brain tumors: initial results of a comparative study. Eur J Nucl Med. 2000;27:542-549.